Summary
Highlights
The official guidance on daily aspirin use has shifted. Previously, it was recommended for individuals over a certain age to prevent a first heart attack or stroke. However, in 2022, the US Preventive Services Task Force advised against starting daily aspirin for primary prevention in adults aged 60 and older. For those in their 40s and 50s at higher risk, it became an individual decision. This change was often misrepresented in headlines, leading to confusion about its universal applicability.
Most heart attacks are not caused by arteries slowly becoming fully clogged. Studies show that roughly 70% of heart attacks occur in arteries that are less than 50% blocked. Instead, heart attacks are typically triggered by the rupture of a soft, inflamed plaque within the artery wall. This rupture leads to the rapid formation of a blood clot, which then blocks the artery. The real villains are inflammation, unstable plaque, and the resulting clot, not just high cholesterol.
Aspirin works by making platelets less sticky, thereby blunting the initial stage of clot formation. This is why for those experiencing a heart attack, the advice remains to chew an adult aspirin. For secondary prevention (those who have already had a heart attack or stroke), aspirin significantly cuts the risk of a second event by 19-20%. However, aspirin's clot-preventing property also increases the risk of bleeding, primarily in the stomach and gut, and more seriously, in the brain.
The key distinction lies between primary prevention (preventing a first event) and secondary prevention (preventing a subsequent event). For those at high risk (secondary prevention), the benefits of aspirin often outweigh the bleeding risks. For low-risk individuals (primary prevention), the bleeding risk can outweigh the minimal benefits. The change in guidance reflects a smarter approach to matching aspirin to the right person based on their actual cardiovascular risk, often assessed through factors like coronary calcium score.
If plaque were found, the focus should shift to understanding why it formed. Aspirin addresses the consequence (clotting) but not the cause. Seven key strategies are recommended: 1) Control blood sugar (hemoglobin A1C below 5.2%, fasting glucose 70-90 mg/dL) through low-carb diets, fasting, and no food before bed. 2) Reduce insulin resistance (aim for fasting insulin between 2-6) by avoiding snacking, focusing on protein/fats, and eliminating liquid sugars. 3) Reduce visceral fat through quality sleep, sprinting, building lean muscle, and dietary changes. 4) Eliminate ultra-processed foods and industrial seed oils, replacing them with healthy fats like butter, ghee, and olive oil. 5) Walk daily to improve blood flow, release nitric oxide, and blunt post-meal blood sugar spikes. 6) Prioritize quality sleep for blood vessel repair. 7) Adopt an anti-inflammatory, whole-food diet rich in polyphenols and healthy fats.
Extra virgin olive oil has been shown to significantly lower the risk of major cardiovascular events. In the PREDIMED trial, it led to a 30% lower risk. However, it's crucial to choose high-quality, early-harvest, cold-pressed, single-origin olive oil with high polyphenol counts, as many supermarket options are oxidized and lack these beneficial compounds. A simple taste test can reveal the quality: it should have a peppery kick and burn your throat slightly.
Aspirin remains a valuable tool for those with genuine plaque and a doctor's recommendation. However, for low-risk individuals, the bleeding risk may outweigh the benefits. The real question is identifying the problem and for whom. The speaker introduces his new book, "Keto Flex Revised," set to release on July 21st, offering a 45-day plan to lower inflammation, insulin, and visceral fat, customized for different demographics. The key message is that individuals are not doomed by family history or existing plaque, and true prevention starts with building an internal environment that supports healthier arteries through diet and lifestyle, not just medication.